查看所有供应商和价格请点击:
1206681-39-1生产厂家
1206681-39-1价格
化源商城直购
GM-CSF[1]
[1]. Huizinga TWJ, et, al. Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis. Arthritis Res Ther. 2017 Mar 9;19(1):53.